Prima BioMed Ltd (PBMD.OQ)

PBMD.OQ on NASDAQ Stock Exchange Global Market

25 Nov 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for PBMD.OQ


Prima BioMed Ltd is a biotechnology company is engaged in the research, development and commercialization of licensed medical biotechnology. The Company focuses on the the development of personalized immunocellular therapeutic products for the treatment of cancer. The Company’s lead product is CVac is an autologous dendritic... (more)


Beta: 1.81
Market Cap (Mil.): $45.77
Shares Outstanding (Mil.): 1,271.46
Dividend: --
Yield (%): --


  PBMD.OQ Industry Sector
P/E (TTM): -- 228.31 39.03
EPS (TTM): -0.01 -- --
ROI: -51.46 -2.22 17.31
ROE: -51.48 -3.38 18.22
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime
Provider: Edison Investment Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks